APA (7th ed.) Citation

Kasichayanula, S., Liu, X., Pe Benito, M., Yao, M., Pfister, M., LaCreta, F. P., . . . Boulton, D. W. (2013). The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitus. British journal of clinical pharmacology, 76(3), 432-444. https://doi.org/10.1111/bcp.12056

Chicago Style (17th ed.) Citation

Kasichayanula, Sreeneeranj, Xiaoni Liu, Melanie Pe Benito, Ming Yao, Marc Pfister, Frank P. LaCreta, William Griffith Humphreys, and David W. Boulton. "The Influence of Kidney Function on Dapagliflozin Exposure, Metabolism and Pharmacodynamics in Healthy Subjects and in Patients with Type 2 Diabetes Mellitus." British Journal of Clinical Pharmacology 76, no. 3 (2013): 432-444. https://doi.org/10.1111/bcp.12056.

MLA (9th ed.) Citation

Kasichayanula, Sreeneeranj, et al. "The Influence of Kidney Function on Dapagliflozin Exposure, Metabolism and Pharmacodynamics in Healthy Subjects and in Patients with Type 2 Diabetes Mellitus." British Journal of Clinical Pharmacology, vol. 76, no. 3, 2013, pp. 432-444, https://doi.org/10.1111/bcp.12056.